David Davidson, MD
Cardiovascular Disease · Bannockburn, ILNPI 1063679116
Payments from drug & device makers
Across 394 payments — averaging $1220.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$124K
- Amgen$113K
- AstraZeneca$45K
- Novartis$43K
- Akcea Therapeutics, Inc.$35K
- Esperion Therapeutics, Inc.$28K
- plus $92K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 91 | $124,335 |
| Amgen | 95 | $113,093 |
| AstraZeneca | 20 | $44,946 |
| Novartis | 17 | $43,169 |
| Akcea Therapeutics, Inc. | 6 | $34,904 |
| Esperion Therapeutics, Inc. | 23 | $28,431 |
| Regeneron | 3 | $18,000 |
| Astrazeneca UK Limited | 2 | $17,555 |
| Amryt Pharma Holdings Ltd | 12 | $16,718 |
| Sanofi-aventis U.S. LLC | 15 | $13,319 |
| Regeneron Healthcare Solutions, Inc. | 17 | $8,896 |
| Ionis Pharmaceuticals, Inc. | 3 | $8,659 |
| Heartflow, Inc. | 8 | $6,750 |
| Boehringer Ingelheim | 20 | $468 |
| Boston Scientific | 10 | $177 |
| Merck | 7 | $160 |
| Medtronic | 3 | $148 |
| E.r. Squibb & Sons, L.L.C. | 6 | $146 |
| Abiomed | 5 | $142 |
| Johnson & Johnson | 6 | $119 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $114 |
| Abbott | 5 | $107 |
| Pfizer | 3 | $95 |
| Bridgebio Pharma, Inc. | 4 | $95 |
| Lilly USA, LLC | 3 | $50 |
| Lexicon Pharmaceuticals, Inc. | 2 | $40 |
| Scpharmaceuticals Inc. | 2 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $31 |
| Lantheus Medical Imaging, Inc. | 1 | $25 |
| Bayer | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
How this compares
$480,788 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Bannockburn
- Jay AlexanderBannockburn$744K
- Ronald BergerBannockburn$150K
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Steven LupovitchArlington Heights$2.6M
- Nitasha SarswatChicago$2M
- Alan BrownNaperville$1.5M
- Alexander AdlerPeoria$1.5M
- Clifford KavinskyMaywood$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.